CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
August 2021—Euroimmun launched its SARS-CoV-2 NeutraLISA assay, a surrogate neutralization test intended for the detection of neutralizing antibodies against SARS-CoV-2.
The CE-marked assay is based on ELISA technology and uses nonpathogenic viral proteins and can be processed in common laboratory settings, the company says, either manually or automatically.
Pages: 1 2